{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,6,4]],"date-time":"2026-06-04T11:44:43Z","timestamp":1780573483676,"version":"3.54.1"},"reference-count":21,"publisher":"Springer Science and Business Media LLC","issue":"10","license":[{"start":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T00:00:00Z","timestamp":1536537600000},"content-version":"tdm","delay-in-days":0,"URL":"http:\/\/www.springer.com\/tdm"}],"content-domain":{"domain":["link.springer.com"],"crossmark-restriction":false},"short-container-title":["Curr Oncol Rep"],"published-print":{"date-parts":[[2018,10]]},"DOI":"10.1007\/s11912-018-0725-7","type":"journal-article","created":{"date-parts":[[2018,9,10]],"date-time":"2018-09-10T03:30:17Z","timestamp":1536550217000},"update-policy":"https:\/\/doi.org\/10.1007\/springer_crossmark_policy","source":"Crossref","is-referenced-by-count":10,"title":["Building a Cardio-Onco-Hematology Program"],"prefix":"10.1007","volume":"20","author":[{"given":"Joerg","family":"Herrmann","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Charles","family":"Loprinzi","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Kathryn","family":"Ruddy","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"297","published-online":{"date-parts":[[2018,9,10]]},"reference":[{"key":"725_CR1","doi-asserted-by":"publisher","first-page":"14","DOI":"10.1093\/jnci\/djp440","volume":"102","author":"APG Albini","year":"2010","unstructured":"Albini APG, Donatelli F, Cammarota R, De Flora S, Noonan DM. Cardiotoxicity of anticancer drugs: the need for cardio-oncology and cardio-oncological prevention. J Natl Cancer Inst. 2010;102:14\u201325.","journal-title":"J Natl Cancer Inst"},{"issue":"20","key":"725_CR2","doi-asserted-by":"publisher","first-page":"1644","DOI":"10.1016\/j.jacc.2010.07.023","volume":"56","author":"GJ Yoon","year":"2010","unstructured":"Yoon GJ, Telli ML, Kao DP, Matsuda KY, Carlson RW, Witteles RM. Left ventricular dysfunction in patients receiving cardiotoxic cancer therapies are clinicians responding optimally? J Am Coll Cardiol. 2010;56(20):1644\u201350.","journal-title":"J Am Coll Cardiol"},{"key":"725_CR3","doi-asserted-by":"publisher","first-page":"1287","DOI":"10.1016\/j.mayocp.2014.05.013","volume":"89","author":"J Herrmann LA","year":"2014","unstructured":"LA Herrmann J, Sandhu NP, Villarraga HR, Mulvagh SL, Kohli M. Evaluation and management of patients with heart disease and cancer: cardio-oncology. Mayo Clin Proc. 2014;89:1287\u2013306.","journal-title":"Mayo Clin Proc"},{"key":"725_CR4","doi-asserted-by":"publisher","first-page":"285","DOI":"10.1016\/j.tcm.2014.07.003","volume":"24","author":"J Herrmann LA","year":"2014","unstructured":"LA Herrmann J. An update on cardio-oncology. Trends Cardiovasc Med. 2014;24:285\u201395.","journal-title":"Trends Cardiovasc Med"},{"issue":"7","key":"725_CR5","doi-asserted-by":"publisher","first-page":"1029","DOI":"10.1158\/1055-9965.EPI-16-0133","volume":"25","author":"SM Bluethmann","year":"2016","unstructured":"Bluethmann SM, Mariotto AB, Rowland JH. Anticipating the \u201csilver tsunami\u201d: prevalence trajectories and comorbidity burden among older cancer survivors in the United States. Cancer Epidemiol Biomark Prev. 2016;25(7):1029\u201336.","journal-title":"Cancer Epidemiol Biomark Prev"},{"issue":"7","key":"725_CR6","doi-asserted-by":"publisher","first-page":"847","DOI":"10.1016\/j.cjca.2016.04.014","volume":"32","author":"S Parent","year":"2016","unstructured":"\u2022 Parent S, Pituskin E, Paterson DI. The cardio-oncology program: a multidisciplinary approach to the care of cancer patients with cardiovascular disease. Can J Cardiol. 2016;32(7):847\u201351. A concise review of the multidisciplinary nature and various elements of the cardio-onco-hematology program. Provides unique wait time proposals for wait times for cardio-onco-hematology clinics.","journal-title":"Can J Cardiol"},{"issue":"7","key":"725_CR7","doi-asserted-by":"publisher","first-page":"1325","DOI":"10.1093\/annonc\/mdv025","volume":"26","author":"J Stairmand","year":"2015","unstructured":"Stairmand J, Signal L, Sarfati D, Jackson C, Batten L, Holdaway M, et al. Consideration of comorbidity in treatment decision making in multidisciplinary cancer team meetings: a systematic review. Ann Oncol. 2015;26(7):1325\u201332.","journal-title":"Ann Oncol"},{"issue":"3","key":"725_CR8","doi-asserted-by":"publisher","first-page":"1013","DOI":"10.1007\/s10549-011-1819-1","volume":"131","author":"LH Land","year":"2012","unstructured":"Land LH, Dalton SO, Jensen MB, Ewertz M. Impact of comorbidity on mortality: a cohort study of 62,591 Danish women diagnosed with early breast cancer, 1990\u20132008. Breast Cancer Res Treat. 2012;131(3):1013\u201320.","journal-title":"Breast Cancer Res Treat"},{"issue":"31","key":"725_CR9","doi-asserted-by":"publisher","first-page":"4952","DOI":"10.1200\/JCO.2006.08.0499","volume":"25","author":"EO Hanrahan","year":"2007","unstructured":"Hanrahan EO, Gonzalez-Angulo AM, Giordano SH, Rouzier R, Broglio KR, Hortobagyi GN, et al. Overall survival and cause-specific mortality of patients with stage T1a,bN0M0 breast carcinoma. J Clin Oncol. 2007;25(31):4952\u201360.","journal-title":"J Clin Oncol"},{"issue":"1","key":"725_CR10","doi-asserted-by":"publisher","first-page":"169","DOI":"10.1016\/S0360-3016(00)00647-7","volume":"48","author":"CK Lee","year":"2000","unstructured":"Lee CK, Aeppli D, Nierengarten ME. The need for long-term surveillance for patients treated with curative radiotherapy for Hodgkin\u2019s disease: University of Minnesota experience. Int J Radiat Oncol Biol Phys. 2000;48(1):169\u201379.","journal-title":"Int J Radiat Oncol Biol Phys"},{"issue":"10","key":"725_CR11","doi-asserted-by":"publisher","first-page":"1122","DOI":"10.1200\/JCO.2015.64.0409","volume":"34","author":"SH Armenian","year":"2016","unstructured":"Armenian SH, Xu L, Ky B, Sun C, Farol LT, Pal SK, et al. Cardiovascular disease among survivors of adult-onset cancer: a community-based retrospective cohort study. J Clin Oncol. 2016;34(10):1122\u201330.","journal-title":"J Clin Oncol"},{"issue":"3","key":"725_CR12","doi-asserted-by":"publisher","first-page":"27","DOI":"10.1007\/s11912-018-0681-2","volume":"20","author":"RW Squires","year":"2018","unstructured":"Squires RW, Shultz AM, Herrmann J. Exercise training and cardiovascular health in cancer patients. Curr Oncol Rep. 2018;20(3):27.","journal-title":"Curr Oncol Rep"},{"issue":"1","key":"725_CR13","doi-asserted-by":"publisher","first-page":"81","DOI":"10.1016\/j.mayocp.2015.09.009","volume":"91","author":"SG Al-Kindi","year":"2016","unstructured":"Al-Kindi SG, Oliveira GH. Prevalence of preexisting cardiovascular disease in patients with different types of cancer: the unmet need for onco-cardiology. Mayo Clin Proc. 2016;91(1):81\u20133.","journal-title":"Mayo Clin Proc"},{"issue":"6","key":"725_CR14","doi-asserted-by":"publisher","first-page":"570","DOI":"10.1016\/j.amjms.2016.01.025","volume":"351","author":"N Bhatia","year":"2016","unstructured":"Bhatia N, Lenihan D, Sawyer DB, Lenneman CG. Getting the SCOOP-survey of cardiovascular outcomes from oncology patients during survivorship. Am J Med Sci. 2016;351(6):570\u20135.","journal-title":"Am J Med Sci"},{"key":"725_CR15","doi-asserted-by":"publisher","first-page":"2739","DOI":"10.1016\/j.jacc.2015.04.059","volume":"65","author":"BA MG","year":"2015","unstructured":"\u2022 MG BA, Carver JR, Chen MH, Freeman AM, Herrmann J, Iliescu C, et al. Cardiovascular health of patients with cancer and cancer survivors: a roadmap to the next level. J Am Coll Cardiol. 2015;65:2739\u201346. Important white paper style document of an cardio-oncololgy expert group comvened by the American College of Cardiology to define the practice landscape. It includes an insightful survey of cardiologists on needs and barriers to cardio-onco-hematology services.","journal-title":"J Am Coll Cardiol"},{"key":"725_CR16","doi-asserted-by":"publisher","first-page":"1193","DOI":"10.1016\/j.jacc.2015.07.033","volume":"66","author":"T Okwuosa","year":"2015","unstructured":"Okwuosa T, Barac A. Burgeoning cardio-oncology programs: challenges and opportunities for early career cardiologists\/faculty directors. J Am Coll Cardiol. 2015;66:1193\u20137.","journal-title":"J Am Coll Cardiol"},{"issue":"2","key":"725_CR17","doi-asserted-by":"publisher","first-page":"347","DOI":"10.1016\/j.hfc.2016.12.011","volume":"13","author":"D Snipelisky","year":"2017","unstructured":"\u2022\u2022 Snipelisky D, Park JY, Lerman A, Mulvagh S, Lin G, Pereira N, et al. How to develop a cardio-oncology clinic. Heart Fail Clin. 2017;13(2):347\u201359. The first article to speficically outline how to develop a cardio-onco-hematology program. It defined three milestones each with three steps. The current article refines this approach.","journal-title":"Heart Fail Clin"},{"issue":"5","key":"725_CR18","doi-asserted-by":"publisher","first-page":"229","DOI":"10.2459\/JCM.0000000000000642","volume":"19","author":"Maria Laura Canale","year":"2018","unstructured":"\u2022 Canale ML, Lestuzzi C, Bisceglia I, Vallerio P, Parrini I, Associazione Nazionale Medici Cardiologi Ospedalieri Cardio-Oncology Task F. Cardio-oncology organization patterns in Italy: one size does not fit all. J Cardiovasc Med (Hagerstown). 2018;19(5):229\u2013233. A unique document on the cardio-onco-hematology practice environment in Italy. It emphasizes the different sizes of practice and their advantages and disadvantages as well as potential symbiosis.","journal-title":"Journal of Cardiovascular Medicine"},{"key":"725_CR19","doi-asserted-by":"publisher","first-page":"1","DOI":"10.1186\/s40959-016-0014-2","volume":"2","author":"S Barros-Gomes","year":"2016","unstructured":"Barros-Gomes S, Herrmann J, Mulvagh SL, Lerman A, Lin G, Villarraga HR. Rationale for setting up a cardio-oncology unit: our experience at Mayo Clinic. Cardio-Oncology. 2016;2:1\u20139.","journal-title":"Cardio-Oncology"},{"key":"725_CR20","doi-asserted-by":"publisher","first-page":"381","DOI":"10.1016\/j.ijcard.2016.03.237","volume":"214","author":"DMMC Gujral","year":"2016","unstructured":"Gujral DMMC, Lloyd G, Bhattacharyya S. Organisation & models of cardio-oncology clinics. Int J Cardiol. 2016;214:381\u20132.","journal-title":"Int J Cardiol"},{"key":"725_CR21","doi-asserted-by":"publisher","first-page":"935","DOI":"10.1016\/S1470-2045(06)70940-8","volume":"7","author":"AJV Fleissig","year":"2006","unstructured":"Fleissig AJV, Catt S, Fallowfield L. Multidisciplinary teams in cancer care: are they effective in the UK? Lancet Oncol. 2006;7:935\u201343.","journal-title":"Lancet Oncol"}],"container-title":["Current Oncology Reports"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/link.springer.com\/article\/10.1007\/s11912-018-0725-7\/fulltext.html","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-018-0725-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/link.springer.com\/content\/pdf\/10.1007\/s11912-018-0725-7.pdf","content-type":"application\/pdf","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2019,9,9]],"date-time":"2019-09-09T23:11:55Z","timestamp":1568070715000},"score":1,"resource":{"primary":{"URL":"http:\/\/link.springer.com\/10.1007\/s11912-018-0725-7"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2018,9,10]]},"references-count":21,"journal-issue":{"issue":"10","published-print":{"date-parts":[[2018,10]]}},"alternative-id":["725"],"URL":"https:\/\/doi.org\/10.1007\/s11912-018-0725-7","relation":{},"ISSN":["1523-3790","1534-6269"],"issn-type":[{"value":"1523-3790","type":"print"},{"value":"1534-6269","type":"electronic"}],"subject":[],"published":{"date-parts":[[2018,9,10]]},"assertion":[{"value":"10 September 2018","order":1,"name":"first_online","label":"First Online","group":{"name":"ArticleHistory","label":"Article History"}},{"order":1,"name":"Ethics","group":{"name":"EthicsHeading","label":"Compliance with Ethical Standards"}},{"value":"Joerg Herrmann, Charles Loprinzi, and Kathryn Ruddy declare they have no conflict of interest.","order":2,"name":"Ethics","group":{"name":"EthicsHeading","label":"Conflict of Interest"}},{"value":"This article does not contain any studies with human or animal subjects performed by any of the authors.","order":3,"name":"Ethics","group":{"name":"EthicsHeading","label":"Human and Animal Rights and Informed Consent"}}],"article-number":"81"}}